Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin

Published:2019-01-18 Issue:2 Volume:10 Page:463-471
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Chen Ying-Hua,Li Hui-Zhi,Tang Zhao-Sheng,Xu Lei,Wang Hua,Feng Bo

Funder

Pudong Health and Family Planning Commission of Shanghai

Young medical talents in Pudong New District of Shanghai, China

Nation Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13300-019-0564-z.pdf

Reference10 articles.

1. ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.

2. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–59.

3. Mori RC, Hirabara SM, Hirata AE, et al. Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin. Diabetes Obes Metab. 2008;10(7):596–600.

4. Koshiba K, Nomura M, Nakaya Y, et al. Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis. J Med Investig. 2006;53(1–2):87–94.

5. Schiel R, Müller UA. Efficacy and treatment satisfaction of once-daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long-term conventional insulin therapy: the SWITCH Pilot Study. Exp Clin Endocrinol Diabetes. 2008;116(1):58–64.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo therapeutic exploring for Mori folium extract against type 2 diabetes mellitus in rats;Bioscience Reports;2021-12

2. Injectable combination therapies for the management of diabetes: an Indian perspective;Expert Opinion on Drug Metabolism & Toxicology;2020-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3